Use access key #2 to skip to page content.
$66.10 -1.04 (-1.55%)
11/18/2008 4:00 PM

Myriad Genetics, Inc. (MYGN)

CAPS Rating:
****

A biotechnology company focused on the development and marketing of novel therapeutic and molecular diagnostic products.

View All Commentary (MYGN)

Recs

4

Avatar TMFBreakerJava (83.12) Submitted: 6/06/06 5:56 AM : Outperform Start Price: $25.40 MYGN Score: 191.82

Predictive medicine is a growing business that finances the new drug development. Promising pipeline. Buy here, while the market has biotechs on sale.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links